Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD4+ T cell activation in multiple sclerosis.

S J Verselis, J M Goust

    Journal of Neuroimmunology
    |February 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Multiple sclerosis (MS) patients

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patents and literature.

    Applied biochemistry and biotechnology·2013
    Same author

    The effects of calpain inhibition upon IL-2 and CD25 expression in human peripheral blood mononuclear cells.

    Journal of neuroimmunology·2001
    Same author

    Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.

    Oncogene·2000
    Same author

    Common polymorphism in p53 intron 2, IVS2+38G>C.

    Human mutation·2000
    Same author

    Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

    Science (New York, N.Y.)·2000
    Same journal

    Spinal cord microglia exhibit a dysfunctional response to myelin damage.

    Journal of neuroimmunology·2026
    Same journal

    Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

    Journal of neuroimmunology·2026
    Same journal

    Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

    Journal of neuroimmunology·2026
    Same journal

    Serum IDO1 and β-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.

    Journal of neuroimmunology·2026
    Same journal

    Neurological sequelae of Long COVID: Pathophysiological mechanisms, diagnostic advances, and therapeutic perspectives.

    Journal of neuroimmunology·2026
    Same journal

    Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655].

    Journal of neuroimmunology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Neuroscience
    • Cell Biology

    Background:

    • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
    • T cell dysfunction, particularly suppressor T cell activity, is implicated in MS pathogenesis.
    • Interleukin-2 (IL-2) is a critical cytokine for T cell proliferation and function.

    Purpose of the Study:

    • To investigate Interleukin-2 (IL-2) production by CD4+ T cells in multiple sclerosis (MS) patients compared to healthy individuals.
    • To determine if MS CD4+ T cells exhibit altered IL-2 responses to specific stimuli, including B lymphoid cell lines (B-LCL).

    Main Methods:

    • CD4-enriched T cells from MS patients and normal individuals were stimulated with concanavalin A (conA) and/or autologous/allogeneic B-LCL.
    • IL-2 production was measured at 24, 48, and 96 hours post-stimulation.

    Related Experiment Videos

  • Statistical analysis was performed to compare IL-2 levels between groups.

    • Main Results:

    • Concanavalin A (conA)-stimulated CD4+ T cells from MS patients showed no significant difference in IL-2 production compared to controls.
    • However, MS CD4+ T cells produced significantly higher levels of IL-2 when stimulated by autologous B-LCL at 24 hours (P = 0.026).
    • This heightened IL-2 response was most pronounced with allogeneic B-LCL stimulation, suggesting a potential supranormal response to Class II Major Histocompatibility (MHC) associated stimuli in MS.

    Conclusions:

    • The findings suggest that a deficiency in suppressor T cell function in MS may not stem from impaired IL-2 induction.
    • Elevated IL-2 production by MS CD4+ T cells in response to B-LCL indicates a potential role for these cytokine bursts in MS pathogenesis.
    • This supranormal IL-2 response to B-LCL warrants further investigation into its contribution to the inflammatory processes in multiple sclerosis.